UPDATE: Morgan Stanley Maintains Overweight Rating, Raises PT on Colgate-Palmolive

In a report released earlier today, Morgan Stanley maintained its Overweight rating on Colgate-Palmolive Company

and raised its price target from $107.00 to $110.00. Morgan Stanley said in its report “CL is trading at only a slight premium vs. staples peers on an EV/EBITDA basis, despite its superior growth profile, higher EM exposure, better earnings visibility, higher return on invested capital, and greater strategic potential.” Colgate-Palmolive Company closed yesterday at $99.47.